Conference abstract · 18 Jul 2016
Conference abstractPublished 16 Jul 2018
Lisinopril an ACE inhibitor and its effect on Insulin Release.
University of Medical & Health Sciences for Women, Pakistan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hypertension is a persistent raise of resting systolic (≥140mmHg) & diastolic (≥90mmHg) BP (Carretero & Operil, 2000). In normal individuals BP ranges from 120/80mmHg to 140/90mmHg (ISH, 2014). Coronary Heart Diseases (CHD) develops more in diabetic hypertensives than in non-diabetics (James et al., 2000). CHD is the main cause of deaths worldwide. Management of hypertension has decreased the occurrence of stroke, heart failure & renal failure, however events of CHD has not been decreased to that level. On the contrary many antihypertensive drugs have diabetogenic effects via suppression of insulin. The purpose of the study was to observe effects of Lisinopril on insulin release by using rat isolated pancreas (Loubatieries et al., 1972). Diazoxide was used as positive control i.e. known Insulin suppressant drug. Dose used was based on therapeutic peak plasma concentration. Lisinopril at peak plasma level (150ng/ml), did not inhibit Insulin secretions significantly. In conclusion, at peak plasma level Lisinopril did not show any negative effect on Insulin release.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2013
Direct Determination of Four ACE-Inhibitors Lisinopril, Enalapril, Captopril and Fosinopril in Pharmaceuticals and Serum by HPLC
Conference abstract · 17 Oct 2016
What are the roles of ace-inhibitors and angiotensin receptor blockers in adult diabetics with hypertension or chronic kidney diseases?
Conference abstract · 2 Jul 2012
Homology modeling and docking studies between angiotensin-converting enzymes (ACE) and lisinopril
Editorial · 30 May 2024
Revolutionizing Insulin Delivery: Smart Implants for Continuous Monitoring and Release
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Ghulam Rasool Mashori”